Literature DB >> 19039244

Active and passive smoking and risk of narcolepsy in people with HLA DQB1*0602: a population-based case-control study.

Thanh G N Ton1, W T Longstreth, Thomas Koepsell.   

Abstract

BACKGROUND: We examined the risk of narcolepsy associated with active and passive smoking among genetically susceptible individuals.
METHODS: We conducted a population-based case-control study in King County, Wash., USA. Between 2001 and 2005, we enrolled 67 cases through physicians and public outreach, and 95 controls through random-digit dialing. Subjects were aged between 18 and 50 years and positive for HLA DQB1*0602. All subjects were administered in-person interviews about their history of active and passive smoking.
RESULTS: We observed an increased risk of narcolepsy associated with having lived with two or more household smokers (odds ratio, OR = 5.1; 95% confidence interval, CI: 1.6, 12.1); with a grandparent or a sibling who smoked (OR = 3.0; 95% CI: 1.1, 8.3); with a non-family household member who smoked (OR = 3.7; 95% CI: 1.6, 8.6); and with an unrelated smoker for 1-2 years (OR = 3.1; 95% CI: 1.0, 9.0). The risk of narcolepsy was not associated with exposure to smoke at work or with active smoking before age 21 or before age of narcolepsy onset.
CONCLUSION: Passive smoking may be a risk factor for narcolepsy in subjects with HLA DQB1*0602. Future studies could help clarify whether passive smoking is an important etiologic component of narcolepsy among genetically susceptible individuals. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19039244      PMCID: PMC2970624          DOI: 10.1159/000177037

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  28 in total

1.  Active and passive smoking in breast cancer.

Authors:  Alfredo Morabia
Journal:  Epidemiology       Date:  2002-11       Impact factor: 4.822

2.  A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Authors:  Miguel A Hernán; Bahi Takkouche; Francisco Caamaño-Isorna; Juan J Gestal-Otero
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

3.  Randomized recruitment in case-control studies.

Authors:  C R Weinberg; D P Sandler
Journal:  Am J Epidemiol       Date:  1991-08-15       Impact factor: 4.897

4.  Differences between smokers, ex-smokers, passive smokers and non-smokers.

Authors:  A Thornton; P Lee; J Fry
Journal:  J Clin Epidemiol       Date:  1994-10       Impact factor: 6.437

Review 5.  Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies.

Authors:  L Fratiglioni; H X Wang
Journal:  Behav Brain Res       Date:  2000-08       Impact factor: 3.332

6.  Health effects related to environmental tobacco smoke exposure in children in the United States: data from the Third National Health and Nutrition Examination Survey.

Authors:  D M Mannino; J E Moorman; B Kingsley; D Rose; J Repace
Journal:  Arch Pediatr Adolesc Med       Date:  2001-01

Review 7.  Post-streptococcal autoimmune disorders of the central nervous system.

Authors:  Lisa A Snider; Susan E Swedo
Journal:  Curr Opin Neurol       Date:  2003-06       Impact factor: 5.710

Review 8.  Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies.

Authors:  Luc Letenneur; Sophie Larrieu; Pascale Barberger-Gateau
Journal:  Biomed Pharmacother       Date:  2004-03       Impact factor: 6.529

9.  Prevalence of narcolepsy in King County, Washington, USA.

Authors:  W T Longstreth; Thanh G N Ton; Thomas Koepsell; Vivian H Gersuk; Audrey Hendrickson; Sarah Velde
Journal:  Sleep Med       Date:  2008-11-13       Impact factor: 3.492

Review 10.  The genetics of narcolepsy.

Authors:  Dorothee Chabas; Shahrad Taheri; Corinne Renier; Emmanuel Mignot
Journal:  Annu Rev Genomics Hum Genet       Date:  2003       Impact factor: 8.929

View more
  7 in total

1.  Associations between narcolepsy and consumption of alcohol and caffeinated beverages among genetically susceptible individuals: a population-based case-control study.

Authors:  Thanh G N Ton; Nathaniel F Watson; W T Longstreth
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

2.  Birth order and narcolepsy risk among genetically susceptible individuals: a population-based case-control study.

Authors:  Nathaniel F Watson; Thanh G N Ton; Thomas D Koepsell; W T Longstreth
Journal:  Sleep Med       Date:  2012-01-26       Impact factor: 3.492

3.  Narcolepsy and streptococcal infections.

Authors:  W T Longstreth; Thanh G N Ton; Thomas D Koepsell
Journal:  Sleep       Date:  2009-12       Impact factor: 5.849

4.  Narcolepsy with cataplexy masked by the use of nicotine.

Authors:  Matthew R Ebben; Ana C Krieger
Journal:  J Clin Sleep Med       Date:  2012-04-15       Impact factor: 4.062

5.  Environmental toxins and risk of narcolepsy among people with HLA DQB1*0602.

Authors:  Thanh G N Ton; W T Longstreth; Thomas D Koepsell
Journal:  Environ Res       Date:  2010-06-01       Impact factor: 6.498

6.  IgG abnormality in narcolepsy and idiopathic hypersomnia.

Authors:  Susumu Tanaka; Makoto Honda
Journal:  PLoS One       Date:  2010-03-05       Impact factor: 3.240

7.  Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset.

Authors:  Adi Aran; Ling Lin; Sona Nevsimalova; Giuseppe Plazzi; Seung Chul Hong; Karin Weiner; Jamie Zeitzer; Emmanuel Mignot
Journal:  Sleep       Date:  2009-08       Impact factor: 5.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.